Literature DB >> 23825365

Endothelial Von Willebrand factor promotes blood-brain barrier flexibility and provides protection from hypoxia and seizures in mice.

Georgette L Suidan1, Alexander Brill, Simon F De Meyer, Jaymie R Voorhees, Stephen M Cifuni, Jessica E Cabral, Denisa D Wagner.   

Abstract

OBJECTIVE: Aberrant blood-brain barrier (BBB) permeability is a hallmark pathology of many central nervous system diseases. von Willebrand factor (VWF) is stored in endothelial Weibel-Palade bodies from where it is released on activation into plasma and basement membrane. The role of VWF in endothelial homeostasis is unclear. The goal of this study was to assess the role of VWF in disease models associated with increased BBB permeability. APPROACH AND
RESULTS: We did not find any differences in BBB permeability to Evans blue dye at baseline between wild-type and VWF(-/-) animals. We next used 2 models presenting with increased BBB permeability, hypoxia/reoxygenation and pilocarpine-induced status epilepticus, to assess the response of VWF(-/-) animals. In both models, VWF(-/-) mice maintained a tighter BBB than wild-type mice. VWF(-/-) mice fared worse in both conditions, with ≈ 100% of VWF(-/-) mice dying within 120 minutes after pilocarpine administration, whereas >80% of wild-type animals survived. Investigation into the status of tight junction proteins revealed that VWF(-/-) mice expressed more claudin-5 at baseline. In vitro work confirmed that the presence of subendothelial VWF is inhibitory to claudin-5 expression.
CONCLUSIONS: VWF deficiency confers partial preservation of BBB integrity after hypoxia/reoxygenation and seizures. Surprisingly, this decrease in BBB permeability did not result in protection of animals because they demonstrated more severe pathology in both models compared with wild-type animals. These data suggest that a rigid BBB is detrimental (to the organism) during certain disease states and that VWF release may provide desired flexibility under stress.

Entities:  

Keywords:  blood vessels; blood–brain barrier; claudin-5; endothelium; hypoxia; seizures; von Willebrand factor

Mesh:

Substances:

Year:  2013        PMID: 23825365      PMCID: PMC3854012          DOI: 10.1161/ATVBAHA.113.301362

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  65 in total

1.  Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice.

Authors:  C V Denis; P André; S Saffaripour; D D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

Review 2.  Blood-brain barrier disruption in multiple sclerosis.

Authors:  Alireza Minagar; J Steven Alexander
Journal:  Mult Scler       Date:  2003-12       Impact factor: 6.312

Review 3.  Neurofilaments in health and disease.

Authors:  T Gotow
Journal:  Med Electron Microsc       Date:  2000

Review 4.  Transport of glutamate and other amino acids at the blood-brain barrier.

Authors:  Q R Smith
Journal:  J Nutr       Date:  2000-04       Impact factor: 4.798

5.  Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins.

Authors:  P André; C V Denis; J Ware; S Saffaripour; R O Hynes; Z M Ruggeri; D D Wagner
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

6.  Secretion pores in human endothelial cells during acute hypoxia.

Authors:  T Goerge; A Niemeyer; P Rogge; R Ossig; H Oberleithner; S W Schneider
Journal:  J Membr Biol       Date:  2002-06-01       Impact factor: 1.843

7.  The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies.

Authors:  Ulrike Fiedler; Marion Scharpfenecker; Stefanie Koidl; Anja Hegen; Verena Grunow; Jarno M Schmidt; Wilhelm Kriz; Gavin Thurston; Hellmut G Augustin
Journal:  Blood       Date:  2004-02-19       Impact factor: 22.113

8.  Antagonism of NMDA receptors by sigma receptor ligands attenuates chemical ischemia-induced neuronal death in vitro.

Authors:  Toshiaki Kume; Hiroyuki Nishikawa; Ryota Taguchi; Asami Hashino; Hiroshi Katsuki; Shuji Kaneko; Masabumi Minami; Masamichi Satoh; Akinori Akaike
Journal:  Eur J Pharmacol       Date:  2002-11-29       Impact factor: 4.432

9.  Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy.

Authors:  Luca Vignatelli; Caterina Tonon; Roberto D'Alessandro
Journal:  Epilepsia       Date:  2003-07       Impact factor: 5.864

10.  Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain.

Authors:  Heike J Schoch; Silvia Fischer; Hugo H Marti
Journal:  Brain       Date:  2002-11       Impact factor: 13.501

View more
  31 in total

Review 1.  Role of the Golgi Apparatus in the Blood-Brain Barrier: Golgi Protection May Be a Targeted Therapy for Neurological Diseases.

Authors:  Shuwen Deng; Hui Liu; Ke Qiu; Hong You; Qiang Lei; Wei Lu
Journal:  Mol Neurobiol       Date:  2017-07-20       Impact factor: 5.590

2.  A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malaria.

Authors:  Niamh O'Regan; Kristina Gegenbauer; Jamie M O'Sullivan; Sanaz Maleki; Teresa M Brophy; Niall Dalton; Alain Chion; Padraic G Fallon; Georges E Grau; Ulrich Budde; Owen P Smith; Alister G Craig; Roger J S Preston; James S O'Donnell
Journal:  Blood       Date:  2015-10-28       Impact factor: 22.113

3.  An integrative microfluidically supported in vitro model of an endothelial barrier combined with cortical spheroids simulates effects of neuroinflammation in neocortex development.

Authors:  Martin Raasch; Knut Rennert; Tobias Jahn; Claudia Gärtner; Gilbert Schönfelder; Otmar Huber; Andrea E M Seiler; Alexander S Mosig
Journal:  Biomicrofluidics       Date:  2016-07-05       Impact factor: 2.800

4.  Development of a cell line from the American eel brain expressing endothelial cell properties.

Authors:  Sophia R Bloch; Nguyen T K Vo; Sarah K Walsh; Cici Chen; Lucy E J Lee; Peter V Hodson; Niels C Bols
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-12-29       Impact factor: 2.416

Review 5.  Hypoxic Stress and Inflammatory Pain Disrupt Blood-Brain Barrier Tight Junctions: Implications for Drug Delivery to the Central Nervous System.

Authors:  Jeffrey J Lochhead; Patrick T Ronaldson; Thomas P Davis
Journal:  AAPS J       Date:  2017-03-28       Impact factor: 4.009

Review 6.  Diverse activities of von Willebrand factor in traumatic brain injury and associated coagulopathy.

Authors:  Xin Xu; Rosemary Kozar; Jianning Zhang; Jing-Fei Dong
Journal:  J Thromb Haemost       Date:  2020-10-06       Impact factor: 5.824

7.  Von Willebrand factor as a thrombotic and inflammatory mediator in critical illness.

Authors:  William E Plautz; Zachary A Matthay; Marian A Rollins-Raval; Jay S Raval; Lucy Z Kornblith; Matthew D Neal
Journal:  Transfusion       Date:  2020-06-01       Impact factor: 3.157

8.  von Willebrand factor enhances microvesicle-induced vascular leakage and coagulopathy in mice with traumatic brain injury.

Authors:  Yingang Wu; Wei Liu; Yuan Zhou; Tristan Hilton; Zilong Zhao; Wei Liu; Min Wang; Jason Yeon; Katie Houck; Perumal Thiagarajan; Fangyi Zhang; Fu-Dong Shi; Xiaoping Wu; Min Li; Jing-Fei Dong; Jianning Zhang
Journal:  Blood       Date:  2018-06-25       Impact factor: 25.476

9.  17β-estradiol modulates gene expression in the female mouse cerebral cortex.

Authors:  Gwendolyn I Humphreys; Yvonne S Ziegler; Ann M Nardulli
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

10.  Von Willebrand Factor Gene Variants Associate with Herpes simplex Encephalitis.

Authors:  Nada Abdelmagid; Biborka Bereczky-Veress; Santosh Atanur; Alena Musilová; Václav Zídek; Laura Saba; Andreas Warnecke; Mohsen Khademi; Marie Studahl; Elisabeth Aurelius; Anders Hjalmarsson; Ana Garcia-Diaz; Cécile V Denis; Tomas Bergström; Birgit Sköldenberg; Ingrid Kockum; Timothy Aitman; Norbert Hübner; Tomas Olsson; Michal Pravenec; Margarita Diez
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.